Canandaigua National Trust of Florida’s AstraZeneca AZN Stock Holding History

Canandaigua National Trust of Florida’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,547	Closed	-$1.02M	–	112
2025 Q4	$1.02M	Buy	5,547 +297	+6%	+$52.1K	0.64%	34
2025 Q3	$806K	Sell	5,250 -363	-6%	-$54.9K	0.64%	39
2025 Q2	$784K	Buy	5,613 +3,415	+155%	+$479K	0.56%	47
2025 Q1	$323K	Buy	2,198 +110	+5%	+$15.9K	0.28%	82
2024 Q4	$274K	Sell	2,088 -1,486	-42%	-$208K	0.21%	100
2024 Q3	$557K	Buy	+3,574	New	+$577K	0.48%	52

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Canandaigua National Trust of Florida's AZN Position: Q1 2026 in Review

Canandaigua National Trust of Florida sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 5,547 shares — an estimated $1.02M sold.

Canandaigua National Trust of Florida first reported a position in AZN in Q3 2024 and held it in 6 quarters. The position peaked at $1.02M in Q4 2025. 1,383 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Canandaigua National Trust of Florida reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
Canandaigua National Trust of Florida sold 5,547 AstraZeneca shares in Q1 2026, an estimated $1.02M.
Canandaigua National Trust of Florida first reported a position in AstraZeneca in Q3 2024 and held it in 6 quarters.
Canandaigua National Trust of Florida's AstraZeneca position peaked at $1.02M in Q4 2025.
1,383 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Canandaigua National Trust of Florida's 13F filing for Q1 2026, filed 8 Apr 2026.